Humphries William D.

CIK 00016742785 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001674278

Recent Transactions

50 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 33,525 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2024-06-20+45,000→ 45,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 28,732 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2023-09-22$0.40/sh+22,727→ 51,040 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2023-09-22−22,727→ 0 total
Award
STRATA Skin Sciences, Inc.$SSKN
SSKN Common Stock
2023-07-05$1.03/sh+36,408→ 109,724 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2023-06-22+30,000→ 30,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 24,072 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+2,538→ 2,538 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19−2,538→ 0 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2022-06-22+30,000→ 30,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 19,565 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+2,538→ 2,538 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+11,842→ 11,842 total
Purchase
STRATA Skin Sciences, Inc.$SSKN
SSKN Common Stock
2022-03-25$1.73/sh+16,950→ 484,440 total
Purchase
STRATA Skin Sciences, Inc.$SSKN
SSKN Common Stock
2022-03-24$1.58/sh+14,783→ 467,490 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Common Stock
2022-01-10$0.15/sh+22,727→ 28,313 total
Exercise/Conversion
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2022-01-10−22,727→ 0 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-09-14+28,000→ 28,000 total
Award
STRATA Skin Sciences, Inc.$SSKN
Non-Qualified Stock Option Agreement for SSKN Common Stock
2021-08-20+411,124→ 452,707 total
Award
STRATA Skin Sciences, Inc.$SSKN
SSKN Common Stock
2021-07-20+21,583→ 41,583 total
Award
STRATA Skin Sciences, Inc.$SSKN
SSKN Common Stock
2021-07-20+20,000→ 20,000 total
Award
Clearside Biomedical, Inc.$CLSDQ
Stock Option (right to buy)
2021-06-10+25,000→ 25,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Sale
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-12-04$19.87/sh−114,055→ 235,035 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Non-qualified Stock Options (right To Purchase)
2020-12-04−114,055→ 0 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-12-04$14.38/sh+114,055→ 349,090 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Non-qualified Stock Options (right To Purchase)
2020-11-27−13,663→ 114,055 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-11-27$14.38/sh+13,663→ 248,698 total
Sale
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-11-27$19.63/sh−13,663→ 235,035 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Non-qualified Stock Options (right To Purchase)
2020-11-24−21,658→ 127,718 total
Sale
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-11-24$19.63/sh−21,658→ 235,035 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-11-24$14.38/sh+21,658→ 258,176 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-11-23$14.38/sh+1,483→ 236,518 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Non-qualified Stock Options (right To Purchase)
2020-11-23−1,483→ 149,376 total

Companies

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103

WAYNE, PA, 19087

View on SEC.gov